<DOC>
	<DOCNO>NCT00000930</DOCNO>
	<brief_summary>The purpose study see HIV react immune system patient recently infect HIV . This study also examine HIV 's resistance anti-HIV drug newly infect patient . Certain population good candidate participation HIV vaccine trial . These group include men sex men , IV drug user , woman risk get HIV heterosexual contact . Learning HIV behaves population become infected help planning future HIV vaccine study .</brief_summary>
	<brief_title>A Study HIV Newly Infected Individuals</brief_title>
	<detailed_description>This study provide opportunity prospectively monitor marker HIV infection disease progression cohorts suitable HIV vaccine trial . The detection change HIV phenotype genotype , clinical progression rate , antiretroviral resistance within study population time important planning future HIV vaccine trial . This study consist two part . Part A include HIV-infected patient enrol HIVNET D01.1 ( infected-participants cohort HIVNET D01 ) whose HIV disease closely monitor characterize . This study continue monitor patient follow-up evaluation every 3 month first 18 month every 6 month thereafter . Part B include newly HIV-infected patient . These patient monitor clinical laboratory evaluation 0 , 1 , 3 , 6 , 9 , 12 , 18 month , every 6 month Year 5 .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection , document enrollment HIVNET D01.1 ( Part A patient ) standard HIV serological test demonstrate HIV infection virologic assay ( Part B patient ) . Part A : Previous enrollment infectedparticipants cohort HIVNET D01 . Part B : Initial HIVseronegativity HIVNET protocol ( HIV vaccine protocol ) test positive HIV subsequent clinic visit . Confirmation HIV infection documentation HIV negative antibody test within 8 month first positive test . Exclusion Criteria Coexisting Condition : Patients follow condition exclude : An obvious psychological/psychiatric disorder would invalidate informed consent process otherwise contraindicate participation study . Prior Medication : Excluded : Participation HIVNET HIV vaccine trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Sexual Partners</keyword>
	<keyword>Drug Resistance , Microbial</keyword>
	<keyword>Cohort Studies</keyword>
	<keyword>Risk Factors</keyword>
	<keyword>Substance Abuse , Intravenous</keyword>
	<keyword>Disease Progression</keyword>
	<keyword>Homosexuality , Male</keyword>
	<keyword>Genotype</keyword>
	<keyword>Phenotype</keyword>
</DOC>